Goldman Sachs Group Inc Vera Therapeutics, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 554,729 shares of VERA stock, worth $14.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
554,729
Previous 599,854
7.52%
Holding current value
$14.9 Million
Previous $26.5 Million
11.5%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VERA
# of Institutions
192Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$151 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$118 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$90 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$79.8 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$79.5 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $729M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...